GBT Global Blood Therapeutics, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

GBT [NASD]

Global Blood Therapeutics, Inc.

Healthcare | Biotechnology | USA

financial highlights | statements

Index	-	P/E	-	EPS (ttm)	-3.41	Insider Own	2.40%	Shs Outstand	54.63M	Perf Week	-7.16%
Market Cap	3.00B	Forward P/E	-	EPS next Y	-3.07	Insider Trans	-0.03%	Shs Float	53.97M	Perf Month	7.23%
Income	-174.20M	PEG	-	EPS next Q	-0.94	Inst Own	13.17%	Short Float	14.82%	Perf Quarter	14.49%
Sales	-	P/S	-	EPS this Y	-23.20%	Inst Trans	3.93%	Short Ratio	12.81	Perf Half Y	54.77%
Book/sh	10.81	P/B	5.07	EPS next Y	19.80%	ROA	-31.10%	Target Price	88.23	Perf Year	20.15%
Cash/sh	8.74	P/C	6.27	EPS next 5Y	37.00%	ROE	-33.30%	52W Range	30.15 - 59.95	Perf YTD	33.62%
Dividend	-	P/FCF	-	EPS past 5Y	-30.20%	ROI	-	52W High	-8.51%	Beta	2.12
Dividend %	-	Quick Ratio	14.40	Sales past 5Y	-	Gross Margin	-	52W Low	81.92%	ATR	2.21
Employees	171	Current Ratio	14.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	48.71	Volatility	4.93% 4.25%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	1.40%	Profit Margin	-	Rel Volume	2.02	Prev Close	56.59
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 26	Payout	-	Avg Volume	624.60K	Price	54.85
Recom	1.70	SMA20	-0.93%	SMA50	3.51%	SMA200	23.32%	Volume	1,259,063	Change	-3.07%

Dec-03-18

Reiterated

H.C. Wainwright

Buy

$125 → $150

Aug-06-18

Initiated

Piper Jaffray

Overweight

$80

Jun-27-18

Reiterated

H.C. Wainwright

Buy

$73 → $125

Jun-27-18

Reiterated

Cantor Fitzgerald

Overweight

$69 → $96

May-08-18

Reiterated

SunTrust

Buy

$80 → $77

Mar-21-18

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Feb-28-18

Reiterated

Cantor Fitzgerald

Overweight

$61 → $72

Feb-14-18

Initiated

Janney

Buy

Jan-23-18

Initiated

William Blair

Outperform

Dec-14-17

Reiterated

Needham

Buy

$51 → $70

Dec-01-17

Initiated

H.C. Wainwright

Buy

$73

Sep-21-17

Initiated

Needham

Buy

$51

Aug-08-17

Reiterated

JP Morgan

Overweight

$44 → $46

Apr-18-17

Initiated

SunTrust

Buy

$56

Mar-21-17

Resumed

Wedbush

Outperform

$73

Mar-16-17

Initiated

Cantor Fitzgerald

Overweight

$61

Mar-02-17

Initiated

Instinet

Buy

$50

Jan-04-17

Initiated

JP Morgan

Overweight

Nov-01-16

Initiated

ROTH Capital

Buy

$47

Oct-25-16

Reiterated

Wedbush

Outperform

$66 → $73

Apr-03-19 08:00AM	GBT Announces New Employment Inducement Grants GlobeNewswire +6.86%
Apr-02-19 08:00AM	GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire
Mar-08-19 01:31PM	Announcing: Global Blood Therapeutics (NASDAQ:GBT) Stock Increased An Energizing 211% In The Last Three Years Simply Wall St.
Mar-06-19 08:00AM	GBT Announces New Employment Inducement Grants GlobeNewswire -5.80%
Mar-04-19 08:25AM	Detailed Research: Economic Perspectives on Intelsat S.A, Sprint, Restaurant Brands International, Tower Semiconductor, TE Connectivity, and Global Blood Therapeutics What Drives Growth in Today's Competitive Landscape GlobeNewswire
08:00AM	GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-28-19 09:28AM	Aiming at genetic diseases, Peninsula stealth biotech emerges with $191 million American City Business Journals
Feb-27-19 04:05PM	GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results GlobeNewswire
Feb-21-19 08:00AM	GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-19-19 08:00AM	GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease GlobeNewswire
Feb-05-19 10:52AM	Why Global Blood Therapeutics Surged 16.7% Higher in January Motley Fool
08:00AM	GBT Announces New Employment Inducement Grants GlobeNewswire
Feb-01-19 09:48AM	6 Biotech Stocks to Watch Now Motley Fool
Jan-29-19 04:05PM	GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease GlobeNewswire
Jan-22-19 06:55PM	Should You Sell CRISPR Therapeutics Following an Analyst Downgrade? Motley Fool
Jan-03-19 04:05PM	GBT Announces New Employment Inducement Grants GlobeNewswire
Jan-02-19 04:05PM	GBT to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-18 01:30PM	GBT Appoints Dawn Svoronos to Board of Directors GlobeNewswire
Dec-13-18 08:32AM	Ghost Tree Capitals AUM, Returns and Holdings Insider Monkey
Dec-11-18 03:17PM	Top 6 Performing IPOs of 2015 (ONCE, GBT) Investopedia
12:05PM	Here's Why Global Blood Therapeutics Fell 10.1% in November, Then Jumped 37% Since Motley Fool
Dec-10-18 07:15AM	Global Blood Therapeutics, Voxelotor in Advanced Clinicals, Analysts Review and Target ACCESSWIRE
Dec-07-18 09:15AM	Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering GlobeNewswire -8.60%
08:04AM	The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut Benzinga
07:00AM	3 Biotech Stocks That Could Explode Higher in 2019 SmarterAnalyst
Dec-06-18 04:05PM	Global Blood Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire
01:48PM	3 Top Stocks After #ASH18 Motley Fool
Dec-05-18 09:39AM	Jim Cramer Advises His Viewers On Adobe, Barnes & Noble And More Benzinga
Dec-04-18 06:48PM	Cramer's lightning round: Barnes & Noble's stock is trading like it could get acquired CNBC
04:05PM	GBT Announces New Employment Inducement Grants GlobeNewswire
09:30AM	Company News For Dec 4, 2018 Zacks
09:15AM	Stocks Jump 1% on 90-Day Tariff Delay Zacks
08:13AM	Global Blood Therapeutics' Voxelotor on Faster Approval Path Zacks
07:00AM	Today's Research Reports on Trending Tickers: Regeneron Pharmaceuticals and Global Blood Therapeutics ACCESSWIRE
Dec-03-18 11:55AM	Global Blood's Sickle Cell Disease Drug Snags Accelerated FDA Approval Pathway Benzinga +47.81%
10:37AM	Why Global Blood Therapeutics Skyrocketed Today Motley Fool
10:01AM	Global Blood Therapeutics stock up 40% after FDA agrees to accelerated approval pathway for sickle cell disease drug MarketWatch
10:00AM	GBT Announces Positive 24-week Results from Phase 3 HOPE Study Demonstrating Clinically and Statistically Significant Improvements in Hemoglobin and Clinical Measures of Hemolysis and a Favorable Safety Profile GlobeNewswire
08:00AM	GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA) GlobeNewswire
Dec-02-18 07:00PM	GBT to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Provide a Regulatory Update for Voxelotor GlobeNewswire
Nov-30-18 09:15AM	The Market is All Packed for Buenos Aires Zacks
Nov-20-18 08:51AM	Implied Volatility Surging for Global Blood Therapeutics (GBT) Stock Options Zacks
Nov-09-18 07:25AM	Report: Exploring Fundamental Drivers Behind California Water Service Group Holding, Canadian Solar, JELD-WEN Holding, CONSOL Coal Resources LP, Global Blood Therapeutics, and Pier 1 Imports New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-08-18 05:34PM	Eyeing faster path for sickle cell drug, Peninsula biotech plots expansion for a higher price American City Business Journals
07:05AM	Today's Research Reports on Trending Tickers: Portola Pharmaceuticals and Global Blood Therapeutics ACCESSWIRE
Nov-07-18 08:24AM	3 Top Biotech Stocks to Buy in November Motley Fool +5.17%
Nov-06-18 07:13PM	Global Blood: 3Q Earnings Snapshot Associated Press
04:05PM	GBT Reports Recent Business Progress and Provides Third Quarter 2018 Financial Results GlobeNewswire
08:00AM	GBT Announces New Employment Inducement Grants GlobeNewswire
Nov-01-18 03:37PM	Lifshitz & Miller LLP Announces Investigation of Access National Corporation, Engility Holdings, Inc., Floor & Decor Holdings, Inc., Global Blood Therapeutics, Inc., Intrexon Corporation, Keryx Biopharmaceuticals, Inc., Nevada Gold & Casinos, Inc., and Sonic Corp. PR Newswire +12.31%
09:00AM	GBT Announces Upcoming Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition GlobeNewswire
Oct-25-18 11:46AM	GUERBET : Revenue at September 30, 2018 GlobeNewswire
Oct-04-18 04:05PM	GBT Announces New Employment Inducement Grants GlobeNewswire
08:00AM	GBT Announces Upcoming Presentations at National Sickle Cell Disease Association of America (SCDAA) Convention GlobeNewswire
Sep-27-18 11:11AM	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Global Blood Therapeutics, Inc. (GBT) GlobeNewswire
08:40AM	Analysis: Positioning to Benefit within CONSOL Coal Resources LP, QTS Realty Trust, MakeMyTrip, Momo, QIWI, and Global Blood Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Sep-26-18 04:05PM	GBT Announces Participation at the 2018 Cantor Global Healthcare Conference GlobeNewswire
Sep-25-18 12:08PM	GUERBET : 2018 half-year results GlobeNewswire
Sep-24-18 07:19PM	Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating Possible Securities Fraud Violations by Certain Officers and Directors of Alnylam, Global Blood, and NiSource on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Sep-18-18 08:20PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Global Blood Therapeutics, Inc. - GBT ACCESSWIRE
Sep-17-18 03:40PM	Oppenheimers 7 Top Stock Picks for September Kiplinger
08:47AM	Are Options Traders Betting on a Big Move in Global Blood (GBT) Stock? Zacks
Sep-14-18 06:07PM	INVESTIGATION ALERT: The Schall Law Firm Announces It is Investigating Claims against Global Blood Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
08:00AM	Today's Research Reports on Trending Tickers: Ironwood Pharmaceuticals and Global Blood Therapeutics ACCESSWIRE
Sep-13-18 06:16PM	EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Global Blood Therapeutics, Inc. GBT Business Wire -7.40%
05:34PM	Bragar Eagel & Squire, P.C. is Investigating Global Blood Therapeutics, Inc. (GBT) on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
04:05PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Global Blood Therapeutics, Inc. - GBT PR Newswire
12:33PM	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Global Blood Therapeutics, Inc. (GBT) PR Newswire
Sep-12-18 06:00PM	Bluebird Bio Stock May Have Upside of at Least 60 Percent InvestorPlace
Sep-07-18 04:05PM	GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference GlobeNewswire
Sep-06-18 04:05PM	GBT Announces New Employment Inducement Grants GlobeNewswire -6.50%
08:00AM	GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference GlobeNewswire
Sep-05-18 08:30AM	3 Biotech Stocks Ready to Burn Up TheStreet.com
Aug-28-18 10:50AM	Oppenheimers 7 Top Stock Picks for September InvestorPlace
Aug-23-18 08:00AM	Today's Research Reports on Trending Tickers: Immunomedics and Global Blood Therapeutics ACCESSWIRE
08:00AM	GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis GlobeNewswire
Aug-21-18 08:00AM	GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy GlobeNewswire
Aug-16-18 08:00AM	Today's Research Reports on Trending Tickers: Cronos Group and Global Blood Therapeutics ACCESSWIRE
Aug-07-18 04:05PM	GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-03-18 04:05PM	GBT Announces New Employment Inducement Grants GlobeNewswire +6.64%
Aug-02-18 06:59PM	Global Blood: 2Q Earnings Snapshot Associated Press
04:05PM	GBT Reports Recent Business Progress and Provides Second Quarter 2018 Financial Results GlobeNewswire
Jul-26-18 03:47PM	A guide to biotechs building boom in South City American City Business Journals
08:20AM	Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Global Blood Therapeutics ACCESSWIRE
08:00AM	Free Technical Insights on BioPharmX and Three Other Biotech Stocks ACCESSWIRE
Jul-04-18 08:00AM	Today's Research Reports on Trending Tickers: Clovis Oncology and Global Blood Therapeutics ACCESSWIRE
Jul-03-18 04:05PM	GBT Announces New Employment Inducement Grants GlobeNewswire
Jun-28-18 08:20AM	Global Blood Therapeutics is making a big gamble on its sickle cell drug MarketWatch +6.03%
08:10AM	Today's Research Reports on Trending Tickers: Global Blood Therapeutics and Cara Therapeutics ACCESSWIRE
Jun-27-18 06:11PM	Why Sangamo Therapeutics and bluebird bio Slipped Lower Today Motley Fool +15.63%
05:14PM	Why Global Blood Therapeutics Surged 10.7% Higher Motley Fool
03:31PM	Why a $500 Million Bet on a Looser FDA Makes Sense Bloomberg
11:12AM	GBT's drug meets trial goal, investors skeptical of speedy approval Reuters
10:05AM	Global Blood Therapeutics Meets Primary Endpoints In Sickle Cell Study, Seeks Accelerated FDA Approval Benzinga
08:35AM	Implied Volatility Surging for Global Blood Therapeutics (GBT) Stock Options Zacks
07:38AM	Global Blood Therapeutics' sickle cell disease drug succeeds in trial Reuters
07:30AM	GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease GlobeNewswire
Jun-25-18 12:50PM	3 Killer Stocks Trading at Unfair Discounts TheStreet.com -7.02%
Jun-15-18 01:06PM	Here's Why Shares of Global Blood Therapeutics Inc Are Falling Today Motley Fool -14.88%
11:33AM	Global Blood Therapeutics Shares Plunge After Sickle Cell Candidate Shows Reduced Effect Benzinga

Global Blood Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. It is developing its lead product candidate, voxelotor, an oral, once-daily therapy for sickle cell disease (SCD). The company is evaluating voxelotor in SCD in a Phase III clinical trial in adult and adolescent patients with SCD. It is also evaluating the safety and pharmacokinetics of single and multiple doses of voxelotor in a Phase IIa clinical trial of adolescent and pediatric patients with SCD. Global Blood Therapeutics, Inc. was founded in 2011 and is headquartered in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Calhoun Lesley Ann	See Remarks	Feb 12	Sale	50.45	354	17,860	1,032	Feb 14 05:29 PM
Farrow Jeffrey S	Chief Financial Officer	Nov 27	Option Exercise	16.40	3,048	49,987	15,555	Nov 28 06:01 PM
Calhoun Lesley Ann	See Remarks	Aug 17	Sale	49.19	300	14,756	838	Aug 20 08:25 PM
Calhoun Lesley Ann	See Remarks	Aug 16	Option Exercise	22.00	1,500	33,000	2,638	Aug 20 08:25 PM
Calhoun Lesley Ann	See Remarks	Aug 16	Sale	50.01	1,704	85,214	1,138	Aug 20 08:25 PM
LOVE TED W	See Remarks	Jul 16	Option Exercise	16.40	12,194	199,982	1,117,979	Jul 17 09:30 PM
Calhoun Lesley Ann	See Remarks	Jul 09	Option Exercise	22.00	2,295	50,490	2,683	Jul 10 06:10 PM
Calhoun Lesley Ann	See Remarks	Jul 09	Sale	44.27	2,295	101,609	388	Jul 10 06:10 PM
Calhoun Lesley Ann	See Remarks	Jul 06	Option Exercise	22.00	1,000	22,000	1,388	Jul 10 06:10 PM
PATRICK DEVAL L	Director	Jul 06	Option Exercise	21.42	42,379	907,631	42,379	Jul 10 06:13 PM
PATRICK DEVAL L	Director	Jul 06	Sale	43.40	42,379	1,839,283	0	Jul 10 06:13 PM
Calhoun Lesley Ann	See Remarks	Jul 06	Sale	44.01	1,000	44,005	388	Jul 10 06:10 PM
Choi Jung	See Remarks	May 17	Option Exercise	3.40	1,400	4,760	137,477	May 21 04:36 PM
Choi Jung	See Remarks	May 17	Sale	48.25	3,000	144,750	136,077	May 21 04:36 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience